Mohamed Ibrahim Sharkawy

Prof. Dr. Mohamed Ibrahim Sharkawy

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TATuna Aras
Tuna Aras
MTMahmoud Tayeh
Mahmoud Tayeh
AAAdel Aswad
Adel Aswad
MSMohamed Ibrahim Sharkawy
Mohamed Ibrahim Sharkawy
PMPayman Majd
Payman Majd
Endoleaks are common complications following endovascular aneurysm repair (EVAR). They can be classified into low-pressure and high-pressure endoleaks. High-pressure endoleaks, which include Type I and Type III endoleaks, pose a significant risk of rupture and require urgent treatment. The aim of our study is to review published case reports and case series to assess the impact of Type IIIb endoleaks in EVAR and to identify possible mechanisms contributing to these endoleaks. This review targeted case reports and case series published between January 1998 and December 2022. A total of 62 case reports and case series were identified, encompassing 156 patients with Type IIIb endoleaks. Data collection was performed by three consultants who thoroughly discussed each report before registering it into an analyzable data set. Our analysis revealed that, beyond material imperfections, certain endograft configurations or conformations, endograft redundancy, and the physical forces acting on the grafts may lead to increased stress on specific parts of the endografts, potentially exceeding their design limits. Factors contributing to redundancy and unfavorable conformation of the endograft include secondary interventions for any cause (such as other types of endoleaks), EVAR performed outside the instructions for use (IFUs), endograft migrations, or larger initial aneurysm diameter.

22 September 2015 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
SBSilke Brunkwall
Silke Brunkwall
WAWael Ahmad
Wael Ahmad
SMSpyridon Mylonas
Spyridon Mylonas
MSMohamed Ibrahim Sharkawy
Mohamed Ibrahim Sharkawy
JWJens Wippermann
Jens Wippermann
JBJan Brunkwall
Jan Brunkwall
Purpose: To describe a technique for trans–ascending aorta through-and-through guidewire placement for thoracic endograft advancement and deployment. Case Report: A 55-year-old man presented with a symptomatic pseudoaneurysm of the distal aortic arch after aortic coarctation open repair. He had also undergone mechanical aortic valve replacement. Planned were a left-sided carotid-subclavian bypass and a thoracic endovascular aortic repair with a chimney graft to the left common carotid artery. After carotid-subclavian bypass, efforts to retrograde cannulate the aortic arch and advance the thoracic endograft were unsuccessful. Because of the mechanical heart valve, no transapical approach could be used. Access to the ascending aorta was gained through a midline sternotomy. A through-and-through wire was positioned from the ascending aorta to femoral artery, which provided the required stability for advancement of the thoracic endograft. Six-month computed tomography documented patent endografts and carotid-subclavian bypass and no evidence of endoleak. Conclusion: A trans–ascending aorta through-and-through guidewire is a feasible adjunct that can be added to the endovascular armamentarium when transcardiac or transbrachial approaches are impossible or ineffective.

1 January 2020 in International Journal of Surgery Open
Verified
Journal Article
Open access
AHAhmed Samir Hosny
Ahmed Samir Hosny
AEAhmed Elmahrouky
Ahmed Elmahrouky
ABAhmed Balboula
Ahmed Balboula
MYMarwan Yousry
Marwan Yousry
MSMohamed Ibrahim Sharkawy
Mohamed Ibrahim Sharkawy
: Introduction: Vascular malformations are localized defects in vascular morphogenesis that are believed to be caused by dysfunction in embryogenesis and vasculogenesis. However, with the development of new vessel sealing devices, surgical removal of the vascular malformations can be safely undertaken. The aim of this study was to test the feasibility of vessel sealing devices in the complete excision of vascular malformations. Methods: We retrospectively analyzed medical records of all patients with vascular malformation who underwent a surgical excision of vascular malformations at our institution from January 2015 to June 2018. All patients were followed up after 1 week; 1, 3, 6 months; and 1 year. Results: We assessed 14 patients with vascular malformation (median age, 21 years; malformation: arteriovenous, n = 5; venous, n = 7; lymphatic, n = 1; and combined, n = 1). These vascular malformations were localized in the right lower (n = 5) and left upper (n = 3) limbs, right upper limb (n = 2), head and neck (n = 3), and chest wall (n = 1). Using vessel sealing instruments, the nidus in AVM was excised, and complete excision of vascular malformations was achieved without depriving the skin of dermal blood supply. One patient died three weeks later due to secondary hemorrhage. Complication related to gangrenous skin over the patella was healed by vacuum-assisted closure therapy. Post-excision MRI after 18 months suggested recurrence in one patient. Conclusion: The use of vessel sealing devices was found to be feasible, for surgical excision of vascular malformations. However, further evidence from larger studies, prefereably randomized controlled trials, is required to support the routine use of these devices. Highlights:

1 January 2020 in Vasa
Verified
Journal Article
Closed access
WAWael Ahmad
Wael Ahmad
HDHiba Deeb
Hiba Deeb
COChristoph Otto
Christoph Otto
EKEgan Leonidovich Kalmykov
Egan Leonidovich Kalmykov
ABArthurs Barkans
Arthurs Barkans
JBJan Sigge Brunkwall
Jan Sigge Brunkwall
Summary: Background: The aim of this study is to evaluate perioperative as well as long-term outcomes in patients operated with carotid endarterectomy (CEA) or stenting (CAS) due to symptomatic or asymptomatic high-grade restenosis of the internal carotid artery (ICA). Patients and methods: In a retrospective analysis of our electronic database including 2980 patients who underwent carotid endarterectomy or stenting due to a symptomatic or asymptomatic high-grade stenosis of the ICA, between 2000 and 2016, we enrolled 111 patients with recurrent ICA stenosis. Results: An ipsilateral 2nd time restenosis (> 80 % in the asymptomatic and > 50 % in the symptomatic patients according to NASCET criteria) of ICA was detected in 13 patients (12 %); 3 of them were symptomatic. These patients were managed with either CEA (n = 5/38 %) or CAS (n = 8/62 %) with no perioperative stroke or death. The stroke-free survival rates at 2 and 8 years for CEA were 98 % and 98 % versus 100 % and 100 % for CAS respectively (P = .271). The type of the initial procedure (patch, CAS or interposition) did not play any significant role for the development of a 2nd time restenosis (P = .841). Conclusions: Redo-CEA/CAS seem to have similar results as primary procedures (as reported in the literature) with favorable periprocedural and long-term outcomes.

20 October 2015 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
PDF file
MSMohamed Ibrahim Sharkawy
Mohamed Ibrahim Sharkawy
ASAyman El Samadoni
Ayman El Samadoni
Aims/Introduction: We devised a simple implementable color‐coded etiological key survey based on six significant categories to screen and manage all diabetic foot patients. The study results were analyzed to verify the impact of this survey.Materials and Methods: First we carried out a retrospective internal survey of all diabetic patients that presented to us during the period from January 2004 to January 2007. We used this analysis to develop the color‐coded etiological survey, and applied it to analyze patients prospectively for 5 years from May 2007 to May 2012. Out of 4,102 diabetic foot patients, 739 patients were referred by other medical facilities for major amputation as a result of the severity of their foot lesions. This group was then subjected to further analysis to study the value and impact of the survey on amputation‐free limb survival.Results: Blood quality abnormalities were most prevalent followed by peripheral occlusive diseases, whereas tissue loss was the least. After the completion of the assessment process, management was implemented according to the defined protocol based on the lesions’ characteristics. The primary end‐point of major amputation‐free limb survival was achieved in 72.5% of patients, with an average hospital stay of 13.3 days. Statistical analysis of the etiological keys showed a significant impact of tissue loss, and previous foot surgery as a poor predictor of limb loss.Conclusion: We conclude that the implementation of the color‐coded etiological key survey can provide efficient and effective service to diabetic foot victims with comparable outcomes to dedicated diabetic foot clinics.

15 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TATuna Aras
Tuna Aras
MTMahmoud Tayeh
Mahmoud Tayeh
AAAdel Aswad
Adel Aswad
MSMohamed Ibrahim Sharkawy
Mohamed Ibrahim Sharkawy
ZAZaki Almuzakki
Zaki Almuzakki
PMPayman Majd
Payman Majd
Background: Peripheral vascular parameters may provide valuable insights into coronary artery disease (CAD) risk stratification. This study aimed to develop a CAD risk score by integrating carotid duplex velocities, ankle–brachial index (ABI), and clinical history into a point-based model. Methods: We analyzed data from 902 cardiology patients, of whom 592 (65.6%) had confirmed CAD based on coronary angiography. Peripheral vascular assessments included carotid duplex ultrasonography and ABI measurements. Predictors were identified through multivariate logistic regression, addressing multicollinearity and interaction effects. A point-based scoring system was developed using statistically significant variables and evaluated via receiver operating characteristic (ROC) analysis. Results: Key predictors included external carotid artery velocities, ABI, carotid stenosis, chronic kidney disease (CKD) stage, smoking history, diabetes, hypertension, and age. The scoring system demonstrated moderate discriminative ability (AUC: 0.683) and high sensitivity (97%) for detecting CAD-positive cases but lower specificity (11%) for CAD-negative cases. Patients were stratified into risk categories, with an optimal threshold of ≥7 points maximizing the F1 score. Conclusions: This novel scoring system highlights the clinical relevance of integrating peripheral vascular assessments into CAD risk models. While its high sensitivity ensures robust detection of CAD-positive patients, future multicenter studies are needed to improve specificity and validate its broader clinical utility.